Bank of New York Mellon Corp Takes $73.64 Million Position in The Cooper Companies, Inc. $COO

Bank of New York Mellon Corp acquired a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 1,026,945 shares of the medical device company's stock, valued at approximately $73,642,000. Bank of New York Mellon Corp owned approximately 0.53% of Cooper Companies as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Heartland Advisors Inc. acquired a new position in Cooper Companies in the 4th quarter valued at approximately $15,348,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in shares of Cooper Companies by 6.0% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 421,948 shares of the medical device company's stock worth $34,224,000 after purchasing an additional 23,896 shares during the period. Capital International Inc. CA lifted its holdings in shares of Cooper Companies by 22.9% during the fourth quarter. Capital International Inc. CA now owns 118,210 shares of the medical device company's stock worth $9,688,000 after purchasing an additional 22,054 shares during the period. Swedbank AB grew its stake in shares of Cooper Companies by 18.8% in the fourth quarter. Swedbank AB now owns 1,074,029 shares of the medical device company's stock worth $88,027,000 after purchasing an additional 170,000 shares during the last quarter. Finally, SEB Asset Management AB bought a new stake in shares of Cooper Companies in the first quarter worth $22,823,000. Institutional investors own 24.39% of the company's stock.

Analyst Ratings Changes

Several research analysts have commented on COO shares. Citigroup reaffirmed a "neutral" rating and set a $80.00 target price (up from $76.00) on shares of Cooper Companies in a report on Thursday, August 13th. Weiss Ratings cut Cooper Companies from a "hold (c-)" rating to a "sell (d)" rating in a research note on Monday, June 8th. The Goldman Sachs Group set a $61.00 price objective on Cooper Companies in a research report on Wednesday, May 27th. Mizuho set a $85.00 price objective on Cooper Companies and gave the stock an "outperform" rating in a research note on Thursday, June 4th. Finally, Wall Street Zen upgraded Cooper Companies from a "hold" rating to a "buy" rating in a report on Sunday, June 21st. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $81.64.

Cooper Companies Trading Down 3.6%

Shares of Cooper Companies stock opened at $73.04 on Wednesday. The stock has a market capitalization of $14.24 billion, a PE ratio of 61.90, a price-to-earnings-growth ratio of 1.98 and a beta of 0.83. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83. The stock has a 50 day moving average price of $72.20 and a two-hundred day moving average price of $71.01. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping analysts' consensus estimates of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same period in the prior year, the firm earned $0.96 earnings per share. Cooper Companies's revenue for the quarter was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Cooper Companies News Summary

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Traders purchased 4,056 call options on COO, roughly 411% above the typical daily volume of 794 contracts. This points to increased speculative bullish interest, although options activity alone does not guarantee a sustained stock advance.
• Neutral Sentiment: The latest short-interest report lists zero shares sold short and a 0.0-day short-interest ratio, but it also describes the change as “NaN” from a prior total of zero. The figures appear inconsistent and provide little useful information about investor positioning. Short Interest Report
• Negative Sentiment: COO’s valuation remains demanding, with a reported P/E ratio near 62. That can make the shares more sensitive to profit-taking or a lack of fresh positive catalysts, even though the company recently exceeded quarterly earnings and revenue expectations and reported year-over-year revenue growth.

About Cooper Companies

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source